QA: Provectus Biopharmaceuticals INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000315545_2025_Provectus_Biopharmaceuticals_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000315545, Provectus Biopharmaceuticals INC

  xvar xval
0 AssetsCurrent 976,772
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,863
3 remainder_Assets 24,624
4 LiabilitiesCurrent 6,975,484
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,249,015
9 ResearchAndDevelopmentExpense 2,014,203
10 remainder_Expenses 0
11 remainder_Revenues 600,401
12 remainder_NetIncome -229,523
13 remainder_ComprehensiveNetIncome -23,543
  yvar yval
0 Assets 1,006,259
1 Liabilities 6,975,484
2 Expenses 5,263,218
3 Revenues 600,401
4 StockholdersEquity -5,969,225
5 NetIncome -4,892,340
6 ComprehensiveNetIncome -4,904,112
7 BaseVar 7,049,214
8 EconomicCapitalRatiobeforeLimitedLiability -4.49
9 EconomicCapitalRatio 0.281

Edgar->Model Mapping

Feature Distribution

Change over Time